BLDE BLADE AIR MOBILITY INC

Blade Air Mobility Announces Date for Fiscal Third Quarter Ended September 30, 2022 Earnings Release Conference Call

Blade Air Mobility Announces Date for Fiscal Third Quarter Ended September 30, 2022 Earnings Release Conference Call

NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the fiscal third quarter ended September 30, 2022 on Wednesday, November 9, 2022 after the market closes. Management will conduct a conference call the same day at 4:30 pm Eastern Time to discuss the results.

Please note that there is a new system to access the live call in order to ask questions. To join the live call, please register . Upon registration, a dial-in and unique PIN will be provided to join the call.

An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at or by registering at the link . A replay of the webcast will be available for one year.

About Blade Air Mobility

Blade is a technology-powered, global air mobility platform committed to reducing travel friction by providing cost-effective air transportation alternatives to some of the most congested ground routes in the U.S. and abroad. Today, the Company predominantly uses helicopters and amphibious aircraft for its passenger routes and is also one of the largest air medical transporters of human organs for transplant in the world. Its asset-light model, coupled with its exclusive passenger terminal infrastructure, is designed to facilitate a seamless transition to Electric Vertical Aircraft (“EVA” or “eVTOL”), enabling lower cost air mobility to the public that is both quiet and emission-free.

For more information, visit .

Contacts

Media Relations

Lee Gold

Investor Relations

Ravi Jani

Source: Blade Air Mobility, Inc.

 



EN
17/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BLADE AIR MOBILITY INC

 PRESS RELEASE

Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Confere...

Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and Melissa Tomkiel, Strata’s Co-Chief Executive Officer and Gener...

 PRESS RELEASE

Strata Announces Closing of Revolving Credit Facility to Support Acqui...

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution $30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditionsOwned aircraft excluded from collateral package and remain unencumbered NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced that the Company has entered into a credit agreement with JPM...

 PRESS RELEASE

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors

Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Strata Critical Medical, Inc. (“Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees. Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health ...

 PRESS RELEASE

Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Med...

Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance Event highlights multiple ongoing industry growth catalysts and a range of factors that should enable Strata to grow faster than the overall marketTeam defines roll-up opportunity, acquisition philosophy and priority targets for $200 million of estimated cash available for deployment through 2029New 2026 financial guidance and medium-term financial framework targets a sustained high-teens target CAGR(1) for Adjusted EBITDA on an organic basisAdjusted EBITDA expected to double organically(1) by ...

 PRESS RELEASE

Strata Critical Medical Announces Third Quarter 2025 Results

Strata Critical Medical Announces Third Quarter 2025 Results Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to $(9.7) million in Q3 2025 versus $(5.6) million in the prior year periodMedical Segment Adjusted EBITDA increased 93.5% in Q3 2025 to $7.6 million versus the prior year period and increased 80.2% excluding the impact of the Keystone acquisition(1)Medical Segment Adjusted EBITDA margin excluding Keystone increased to 15.1% in Q3 2025(1)Raised 2025 revenue guidance to $185-195 milli...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch